Meningococcal Vaccines Market Size, Share, Demand, Analysis and Forecast Report to 2027


Posted October 5, 2020 by pankajrathi

Increase n number of reportable cases of individuals suffering from meningococcal meningitis in the Sub-Saharan African region is the key driving factor which is expected to boost the global meningococcal vaccines market growth.
 
Global Meningococcal Vaccines Market was valued at 1,938 million in 2019 which is expected to reach USD 4,196 million by 2027 at CAGR 9.3%.

The global Meningococcal Vaccines market is studied in detail in the new report on Qualiket Research. The new report studies the Meningococcal Vaccines market by profiling its major driving factors and restraining factors, compiling a comprehensive database on the market’s historical growth trajectory and present conditions, and by using easy formulation of calculations and estimations through the use of industry-leading analytical tools and methods.

Request Sample Copy of this Report @ https://qualiketresearch.com/request-sample/Meningococcal-Vaccines-Market/request-sample

Meningitis is caused by various fungi, bacteria, and viruses. The bacterial form of meningitis is called as meningococcal meningitis which is caused by Neisseria meningitides (meningococcus) bacteria. Meningococcal meningitis disease is prevented by using meningococcal vaccines.

Market Drivers
Increase n number of reportable cases of individuals suffering from meningococcal meningitis in the Sub-Saharan African region is the key driving factor which is expected to boost the global meningococcal vaccines market growth. For instance, in 2018, according to World Economic Forum’s report around 37.4 million tourist arrivals were recorded in Sub-Saharan Africa. Furthermore, increase in government awareness programs as well as rise in government interventions in refining healthcare infrastructure will have the positive impact on growth of global meningococcal vaccines market. Moreover, increase in research & development activities for meningococcal vaccine which is expected to boost the global meningococcal vaccines market growth.

Market Restraints
However, stringent government rules and regulations for approval is the major restraining factor which is expected to hamper the global meningococcal vaccines market growth. Also, product recall of several products due to contamination will affect the global meningococcal vaccines market growth.

Market Key Players
Various key players are discussed in this report such as Serum Institute of India Pvt. Ltd, Emergent BioSolutions, Inc, Sanofi, Merck & Co., Inc, GlaxoSmithKline, plc, and Pfizer Inc.

Market Taxonomy
By Vaccine Serotype
• MenAC
• MenA
• MenC
• MenB & Manic
• MenACWY
By Vaccine Type
• Subcapsular
• Polysaccharide
• Conjugate
By End User
• Adult
• Pediatric
• Travelers
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Browse Full Research Report @ https://qualiketresearch.com/reports-details/Meningococcal-Vaccines-Market

About Us:-
QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition.

Contact Person:-
Vishal Thakur
Research Support Specialist
QualiKet Research
6060 N Central Expy #500, TX 75204, U.S.A
Email: [email protected]
Website: https://qualiketresearch.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By qualiket research
Country India
Categories Business , Health , News
Tags meningococcal vaccines market
Last Updated October 5, 2020